StreetAlpha.app
Home › Stocks › BMY

Bristol Myers Squibb Co (BMY)

Healthcare
$61.38
▼ −2.46%
LAST CLOSE · NOV 17

Bristol Myers Squibb is a pharmaceutical company that develops and sells branded prescription medicines. It last closed at $61.38 on Nov 17, down 2.46% on the day. BMY reports earnings on Thu, Feb 4, 2027. The average 12-month price target from 5 analysts is $59.00 (-3.9% from the last close), with a high of $78.00 and a low of $40.00. Analyst consensus is Hold, based on the latest ratings from 5 firms (1 buy, 3 hold, 1 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in BMY, 50% of them bullish and 50% bearish. In the past 30 days there were 10 dark pool prints totaling $35.6M, the largest $25.9M.

AI Auto Pilots
Is BMY in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$50.0B
+4.2% vs a year ago
Net income
$9.2B
+53.1% vs a year ago
EPS (diluted)
$4.51
+51.9% vs a year ago
Free cash flow
$9.3B
18.6% margin
Valuation
Market cap
$125B
2.04B shares
P/E
13.6
Price over 12 month EPS
Price to sales
2.5
Market cap over revenue
Dividend yield
4.11%
$2.52 a share over 12 months
Balance sheet
Cash & equivalents
$9.6B
At Sep 30
Debt
$42.6B
At Sep 30
Shareholder equity
$23.4B
Shares outstanding
2.04B
At Oct 21
CEOGiovanni Caforio
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $46.4B$46.4BFY2021FY2022: $46.2B$46.2BFY2022FY2023: $45.0B$45.0BFY2023FY2024: $48.3B$48.3BFY2024FY2025: $48.2B$48.2BFY2025

From BMY's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 29). Last 12 months adds up the four latest quarters.

Next report
Feb 4
2027 · Time not announced
Consensus EPS forecast
$1.53
$12.66B revenue est.
Year-ago EPS
$1.26
Same quarter last year
Options-implied move
—
Posted about a week before
Analyst consensus
Hold
Based on 5 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
5firms
1 Buy3 Hold1 Sell
Each firm's latest rating on BMY in the past 90 days
Average 12-month target
$59.00
▼ 3.9% downside

Based on 5 analysts who set a price target on BMY in the past 90 days. The average target is $59.00, with a high of $78.00 and a low of $40.00, compared with the last close of $61.38.

$37$52$66$81PAST 112 TRADING DAYS12-MONTH TARGETSHIGH $78AVG $59LOW $40May 22LAST CLOSE+12 MO$37$52$66$81PAST 112 DAYSTARGETSHIGH $78AVG $59LOW $40May 22LAST CLOSE+12 MO
Highest target$78.00
Average target$59.00
Lowest target$40.00
Latest rating changes
Morgan StanleyTarget lowered
Oct 30Sell$41 → $40
Piper SandlerTarget lowered
Oct 26Buy$82 → $78
Cantor FitzgeraldTarget lowered
Oct 8Hold$59 → $53
Morgan StanleyMaintained
Oct 7Sell$41
Leerink PartnersDowngrade
Oct 5Hold$59
DateFirmActionRatingPrice target
Oct 30Morgan StanleyTarget loweredSell$41 → $40
Oct 26Piper SandlerTarget loweredBuy$82 → $78
Oct 8Cantor FitzgeraldTarget loweredHold$59 → $53
Oct 7Morgan StanleyMaintainedSell$41
Oct 5Leerink PartnersDowngradeHold$59
Loading…

Technical Analysis

BMY · as of the Nov 17 close · updated after every close
Moving sideways

The stock is 1% below its 20 day and 1% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the swing low (Nov 10) at $61.30, and the nearest resistance the 50 day average at $61.75.

Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 3.0%/day
Key levels
$68.6452 week high+11.8%
$62.40100 day average+1.7%
$62.2620 day average+1.4%
$62.25Swing high (Oct 15)+1.4%
$62.12Pivot R1+1.2%
$61.7550 day average+0.6%
$61.38Pivot+0.0%
$61.38Last close
$61.30Swing low (Nov 10)−0.1%
$60.64Pivot S1−1.2%
$60.41200 day average−1.6%
$45.2752 week low−26.2%
Indicators
RSI (14)47.08Middle of its rangeNeutral
MACD0.30Below its signal lineBearish
Stochastic46.6Middle of its rangeNeutral
ADX (14)14.6No clear trend
Williams %R-75.1Oversold below −80, overbought above −20Neutral
CCI (20)-85.1Oversold below −100, overbought above 100Neutral
Rate of change−0.5%Change over 10 sessionsBearish
ATR (14)$1.83Typical daily range, 3.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for BMY

What happened before

See how BMY did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow BMY usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How BMY has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
1
50%
Bearish
1
50%
Date span
Oct 20 – Nov 3
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
10
Notional
$35.6M
Largest print
$25.9M
Loading…

BMY Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●1,174 buying vs 1,089 selling
  • ▼Held by funds -2.3 pts
  • ●Funds holding +25
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call 0.94 to 0.95
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2,5562,531+1.0%
In funds' top 102021−4.8%
Held by funds80.2%82.5%−2.3 pts
New / increased197 / 977146 / 976+4.6%
Reduced / sold out955 / 134984 / 160−4.8%
Put/call ratio0.950.94+0.8%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See BMY institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

BMY Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
—
 
Left in program
$5.0B
4.0% of value
Shares outstanding, 12 months
+0.4%
More shares
Last quarter
$6.7M
Sep 2026
Avg price paid, last quarter
$63.42
105K shares bought
S&P 500 rank by spending
—
 
Spent each quarter, last 3 yearsTop bar $160.9M
Dec 2023: $5.7M, average price $54.87Mar 2024: $129.7M, average price $53.67Jun 2024: $10.3M, average price $48.59Sep 2024: $3.9M, average price $47.24Dec 2024: $7.4M, average price $54.70Mar 2025: $160.9M, average price $62.84Jun 2025: $11.5M, average price $52.79Sep 2025: $4.6M, average price $46.06Dec 2025: $8.4M, average price $47.46Mar 2026: $150.3M, average price $60.02Jun 2026: $11.1M, average price $57.03Sep 2026: $6.7M, average price $63.42
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 29, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BMY is in one of them and how their past BMY trades turned out.

BMY in the AI portfolios
Loading…

BMY News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BMY in an article yet. Here's the latest on the wider market.

BMY Congress Trades

All congress trades →
Trades, 12 months
22
Buys
12
55%
Sells
10
45%
People
7
Last filed Nov 9
Who traded BMY · since 2014
Latest 5 filings of 182
$1K – $15KTraded Oct 13, 2026Filed Nov 9, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Mar 27, 2026Filed Jul 21, 2026
$1K – $15KTraded Jun 16, 2026Filed Jul 6, 2026
$1K – $15KTraded May 18, 2026Filed Jul 1, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 13, 2026Nov 9, 202627 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Alan ArmstrongHouseBuy$1K – $15KMar 27, 2026Jul 21, 2026116 d
Ro KhannaD · CASell$1K – $15KJun 16, 2026Jul 6, 202620 d
Donald J TrumpExecutive branchSell$1K – $15KMay 18, 2026Jul 1, 202644 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Bristol Myers Squibb

Bristol Myers Squibb is a pharmaceutical company based in Princeton, New Jersey. It develops, produces and sells branded prescription medicines, including Eliquis, Opdivo and Orencia, and it continues to research new drugs. Its products are paid for through government programs and commercial insurance plans, so pricing and coverage rules affect its sales.

Headquarters
Princeton, NJ
Founded
1989